Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1993 3
1994 1
1996 1
1997 1
2000 2
2001 1
2002 2
2005 2
2006 1
2007 2
2009 4
2010 2
2011 1
2012 1
2013 2
2015 2
2016 3
2017 3
2018 5
2019 5
2020 14
2021 10
2022 10
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Petrie MC, Verma S, Docherty KF, Inzucchi SE, Anand I, Belohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett J, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O'Meara E, Vinh PN, Schou M, Tereshchenko S, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Ponikowski P, Sabatine MS, Sjöstrand M, Solomon SD, Johanson P, Greasley PJ, Boulton D, Bengtsson O, Jhund PS, McMurray JJV. Petrie MC, et al. Among authors: greasley pj. JAMA. 2020 Apr 14;323(14):1353-1368. doi: 10.1001/jama.2020.1906. JAMA. 2020. PMID: 32219386 Free PMC article. Clinical Trial.
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial.
Cherney DZI, Dekkers CCJ, Barbour SJ, Cattran D, Abdul Gafor AH, Greasley PJ, Laverman GD, Lim SK, Di Tanna GL, Reich HN, Vervloet MG, Wong MG, Gansevoort RT, Heerspink HJL; DIAMOND investigators. Cherney DZI, et al. Among authors: greasley pj. Lancet Diabetes Endocrinol. 2020 Jul;8(7):582-593. doi: 10.1016/S2213-8587(20)30162-5. Lancet Diabetes Endocrinol. 2020. PMID: 32559474 Clinical Trial.
Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF.
Adamson C, Cowan LM, de Boer RA, Diez M, Drożdż J, Dukát A, Inzucchi SE, Køber L, Kosiborod MN, Ljungman CEA, Martinez FA, Ponikowski P, Sabatine MS, Lindholm D, Bengtsson O, Boulton DW, Greasley PJ, Langkilde AM, Sjöstrand M, Solomon SD, McMurray JJV, Jhund PS. Adamson C, et al. Among authors: greasley pj. Eur J Heart Fail. 2022 Oct;24(10):1856-1868. doi: 10.1002/ejhf.2649. Epub 2022 Aug 22. Eur J Heart Fail. 2022. PMID: 36054568 Free PMC article.
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Jackson AM, Dewan P, Anand IS, Bělohlávek J, Bengtsson O, de Boer RA, Böhm M, Boulton DW, Chopra VK, DeMets DL, Docherty KF, Dukát A, Greasley PJ, Howlett JG, Inzucchi SE, Katova T, Køber L, Kosiborod MN, Langkilde AM, Lindholm D, Ljungman CEA, Martinez FA, O'Meara E, Sabatine MS, Sjöstrand M, Solomon SD, Tereshchenko S, Verma S, Jhund PS, McMurray JJV. Jackson AM, et al. Among authors: greasley pj. Circulation. 2020 Sep 15;142(11):1040-1054. doi: 10.1161/CIRCULATIONAHA.120.047077. Epub 2020 Jul 16. Circulation. 2020. PMID: 32673497 Free PMC article. Clinical Trial.
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.
Sen T, Scholtes R, Greasley PJ, Cherney DZI, Dekkers CCJ, Vervloet M, Danser AHJ, Barbour SJ, Karlsson C, Hammarstedt A, Li Q, Laverman GD, Bjornstad P, van Raalte DH, Heerspink HJL. Sen T, et al. Among authors: greasley pj. Diabetes Obes Metab. 2022 Aug;24(8):1578-1587. doi: 10.1111/dom.14729. Epub 2022 Jun 1. Diabetes Obes Metab. 2022. PMID: 35478433 Free PMC article. Clinical Trial.
Urine APOL1 Isoforms Reflect Plasma-Derived Liver-Synthesized Proteins.
Althage M, Heinrich TM, Miliotis T, Bogstedt A, Ma L, Gautreaux MD, Hicks PJ, Palmer ND, MacPhee I, Hartleib-Geschwindner J, Greasley PJ, Freedman BI. Althage M, et al. Among authors: greasley pj. J Am Soc Nephrol. 2021 Oct;32(10):2442-2444. doi: 10.1681/ASN.2021030411. Epub 2021 Jun 23. J Am Soc Nephrol. 2021. PMID: 34162735 Free PMC article. No abstract available.
APOL1 promotes endothelial cell activation beyond the glomerulus.
Carracedo M, Ericson E, Ågren R, Forslöw A, Madeyski-Bengtson K, Svensson A, Riddle R, Christoffersson J, González-King Garibotti H, Lazovic B, Hicks R, Buvall L, Fornoni A, Greasley PJ, Lal M. Carracedo M, et al. Among authors: greasley pj. iScience. 2023 May 8;26(6):106830. doi: 10.1016/j.isci.2023.106830. eCollection 2023 Jun 16. iScience. 2023. PMID: 37250770 Free PMC article.
Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19.
Abraham GR, Kuc RE, Althage M, Greasley PJ, Ambery P, Maguire JJ, Wilkinson IB, Hoole SP, Cheriyan J, Davenport AP. Abraham GR, et al. Among authors: greasley pj. J Mol Cell Cardiol. 2022 Jun;167:92-96. doi: 10.1016/j.yjmcc.2022.03.007. Epub 2022 Mar 23. J Mol Cell Cardiol. 2022. PMID: 35339512 Free PMC article.
77 results